{"id":5106,"date":"2023-03-17T08:43:05","date_gmt":"2023-03-17T08:43:05","guid":{"rendered":"https:\/\/www.eurocytology.eu\/course\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/"},"modified":"2023-04-26T07:39:11","modified_gmt":"2023-04-26T07:39:11","slug":"3-epidemiologie-und-aetiologie-des-zervixkarzinoms","status":"publish","type":"course","link":"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/","title":{"rendered":"3. Epidemiologie und \u00c4tiologie des Zervixkarzinoms"},"content":{"rendered":"<div data-object_id=\"5106\" class=\"cbxwpbkmarkwrap cbxwpbkmarkwrap_guest cbxwpbkmarkwrap_user_cat cbxwpbkmarkwrap-course \"><a  data-redirect-url=\"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/course\/5106\/\"  data-display-label=\"1\" data-show-count=\"1\" data-bookmark-label=\"Bookmark\"  data-bookmarked-label=\"Bookmarked\"  data-loggedin=\"0\" data-type=\"course\" data-object_id=\"5106\" class=\"cbxwpbkmarktrig  cbxwpbkmarktrig-button-addto\" title=\"Bookmark This\" href=\"#\"><span class=\"cbxwpbkmarktrig-label\" >Bookmark (<i class=\"cbxwpbkmarktrig-count\">0<\/i>)<\/span><\/a> <div  data-type=\"course\" data-object_id=\"5106\" class=\"cbxwpbkmarkguestwrap\" id=\"cbxwpbkmarkguestwrap-5106\"><div class=\"cbxwpbkmarkguest-message\"><a href=\"#\" class=\"cbxwpbkmarkguesttrig_close\"><\/a><h3 class=\"cbxwpbookmark-title cbxwpbookmark-title-login\">Please login to bookmark<\/h3><form name=\"loginform\" id=\"loginform\" action=\"https:\/\/www.eurocytology.eu\/wp-login.php\" method=\"post\"><p class=\"login-username\">\n\t\t\t\t<label for=\"user_login\">Benutzername oder E-Mail-Adresse<\/label>\n\t\t\t\t<input type=\"text\" name=\"log\" id=\"user_login\" autocomplete=\"username\" class=\"input\" value=\"\" size=\"20\" \/>\n\t\t\t<\/p><p class=\"login-password\">\n\t\t\t\t<label for=\"user_pass\">Passwort<\/label>\n\t\t\t\t<input type=\"password\" name=\"pwd\" id=\"user_pass\" autocomplete=\"current-password\" spellcheck=\"false\" class=\"input\" value=\"\" size=\"20\" \/>\n\t\t\t<\/p><p class=\"login-remember\"><label><input name=\"rememberme\" type=\"checkbox\" id=\"rememberme\" value=\"forever\" \/> Angemeldet bleiben<\/label><\/p><p class=\"login-submit\">\n\t\t\t\t<input type=\"submit\" name=\"wp-submit\" id=\"wp-submit\" class=\"button button-primary\" value=\"Anmelden\" \/>\n\t\t\t\t<input type=\"hidden\" name=\"redirect_to\" value=\"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/course\/5106\/\" \/>\n\t\t\t<\/p><\/form><p class=\"cbxwpbookmark-guest-register\">No account yet? <a href=\"https:\/\/www.eurocytology.eu\/de\/register\/?redirect_to=https%3A%2F%2Fwww.eurocytology.eu%2Fde%2Fwp-json%2Fwp%2Fv2%2Fcourse%2F5106%2F\">Register<\/a><\/p><\/div><\/div><\/div><h4>Epidemiologie<\/h4>\n<p>Entsprechend der GLOBOSCAN Daten, die von der Internationalen Agentur f\u00fcr Krebsforschung (International Agency for Research into Cancer \/ IARC) im Auftrag der Weltgesundheitsorganisation (World Health Organisation \/ WHO 2012) ver\u00f6ffentlicht wurden, stellt das Zervixkarzinom das 3.h\u00e4ufigste Karzinom und die 4.h\u00e4ufigste Todesursache weltweit dar (Abbildung 3.1). Die h\u00f6chste Morbidi\u00e4t (Frauen, die an einem Zervixkarzinom erkranken) und Mortalit\u00e4t (Frauen die an einem Zervixkarzinom versterben) wird in L\u00e4ndern mit niedrigem sozio\u00f6konomischen Status, unstrukturierten Gesundheitssystemen und unorganisiertem Zervixkarzinom-Screening beobachtet. Laut WHO finden sich ca. 70% der Zervixkarzinomf\u00e4lle in L\u00e4ndern mit niedrigem und mittlerem BIP. F\u00fcr das Jahr 2012 wurden laut WHO weltweit 528.000 Neuerkrankungen und 266.000 Todesf\u00e4lle zu verzeichnet (WHO 2012).<\/p>\n<p>Die H\u00e4ufigkeitsverteilungen von Inzidenz und Mortalit\u00e4t zeigen sowohl weltweit als auch innerhalb von Europa sehr unterschiedliche Werte (Figure 3.1 and Ferlay et al. 2013).&nbsp;<\/p>\n<table border=\"3\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 500px;\">\n<tbody>\n<tr>\n<td>\n<p>Inzidenz und Mortalit\u00e4t innerhalb von Europa<\/p>\n<ul>\n<li>Alterstsandardisierte Durchschnittswerte f\u00fcr die Gesamtinzidenz und \u2013mortalit\u00e4t liegen bei 13.4 und 4.9 auf 100,000 Frauen<\/li>\n<li>Die Spannweite liegt zwischen H\u00f6chstwerten von 34.9 und 14.2 in Rum\u00e4nien und niedrigsten Werten in der Schweiz mit 4.2 und 1.6.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<figure><a data-toggle=\"modal\" href=\"#modal-container-2\"><img fetchpriority=\"high\" decoding=\"async\" alt=\"\" height=\"603\" src=\"http:\/\/lnx.eurocytology.eu\/sites\/default\/files\/styles\/max\/public\/images\/2092_1427721074.png?itok=5RgXbnz3\" width=\"697\" \/><\/a><figcaption>Abbildung 3.1.&nbsp; Krebsinzidenz und -mortalit\u00e4t&nbsp; 2012 weltweit [WHO]<\/figcaption><\/figure>\n<figure><a data-toggle=\"modal\" href=\"#modal-container-2\"><img decoding=\"async\" alt=\"\" height=\"912\" src=\"http:\/\/lnx.eurocytology.eu\/sites\/default\/files\/styles\/max\/public\/images\/2093_1427721092.png?itok=8IsLialX\" width=\"628\" \/><\/a><figcaption>Abbildung 3.2. Inzidenz und Mortalit\u00e4t europaweit (EUCAN)<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<div data-object_id=\"5106\" class=\"cbxwpbkmarkwrap cbxwpbkmarkwrap_guest cbxwpbkmarkwrap_user_cat cbxwpbkmarkwrap-course \"><a  data-redirect-url=\"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/course\/5106\/\"  data-display-label=\"1\" data-show-count=\"1\" data-bookmark-label=\"Bookmark\"  data-bookmarked-label=\"Bookmarked\"  data-loggedin=\"0\" data-type=\"course\" data-object_id=\"5106\" class=\"cbxwpbkmarktrig  cbxwpbkmarktrig-button-addto\" title=\"Bookmark This\" href=\"#\"><span class=\"cbxwpbkmarktrig-label\" >Bookmark (<i class=\"cbxwpbkmarktrig-count\">0<\/i>)<\/span><\/a> <div  data-type=\"course\" data-object_id=\"5106\" class=\"cbxwpbkmarkguestwrap\" id=\"cbxwpbkmarkguestwrap-5106\"><div class=\"cbxwpbkmarkguest-message\"><a href=\"#\" class=\"cbxwpbkmarkguesttrig_close\"><\/a><h3 class=\"cbxwpbookmark-title cbxwpbookmark-title-login\">Please login to bookmark<\/h3><form name=\"loginform\" id=\"loginform\" action=\"https:\/\/www.eurocytology.eu\/wp-login.php\" method=\"post\"><p class=\"login-username\">\n\t\t\t\t<label for=\"user_login\">Benutzername oder E-Mail-Adresse<\/label>\n\t\t\t\t<input type=\"text\" name=\"log\" id=\"user_login\" autocomplete=\"username\" class=\"input\" value=\"\" size=\"20\" \/>\n\t\t\t<\/p><p class=\"login-password\">\n\t\t\t\t<label for=\"user_pass\">Passwort<\/label>\n\t\t\t\t<input type=\"password\" name=\"pwd\" id=\"user_pass\" autocomplete=\"current-password\" spellcheck=\"false\" class=\"input\" value=\"\" size=\"20\" \/>\n\t\t\t<\/p><p class=\"login-remember\"><label><input name=\"rememberme\" type=\"checkbox\" id=\"rememberme\" value=\"forever\" \/> Angemeldet bleiben<\/label><\/p><p class=\"login-submit\">\n\t\t\t\t<input type=\"submit\" name=\"wp-submit\" id=\"wp-submit\" class=\"button button-primary\" value=\"Anmelden\" \/>\n\t\t\t\t<input type=\"hidden\" name=\"redirect_to\" value=\"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/course\/5106\/\" \/>\n\t\t\t<\/p><\/form><p class=\"cbxwpbookmark-guest-register\">No account yet? <a href=\"https:\/\/www.eurocytology.eu\/de\/register\/?redirect_to=https%3A%2F%2Fwww.eurocytology.eu%2Fde%2Fwp-json%2Fwp%2Fv2%2Fcourse%2F5106%2F\">Register<\/a><\/p><\/div><\/div><\/div><p>Epidemiologie Entsprechend der GLOBOSCAN Daten, die von der Internationalen Agentur f\u00fcr Krebsforschung (International Agency for Research into Cancer \/ IARC) im Auftrag der Weltgesundheitsorganisation (World Health Organisation \/ WHO 2012) ver\u00f6ffentlicht wurden, stellt das Zervixkarzinom das 3.h\u00e4ufigste Karzinom und die 4.h\u00e4ufigste Todesursache weltweit dar (Abbildung 3.1). Die h\u00f6chste Morbidi\u00e4t (Frauen, die an einem Zervixkarzinom erkranken) [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":5099,"menu_order":0,"template":"","meta":[],"tags":[],"course_area":[120],"authors":[],"class_list":["post-5106","course","type-course","status-publish","hentry","course_area-zervixzytologie"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>3. Epidemiologie und \u00c4tiologie des Zervixkarzinoms - Eurocytology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"3. Epidemiologie und \u00c4tiologie des Zervixkarzinoms - Eurocytology\" \/>\n<meta property=\"og:description\" content=\"Epidemiologie Entsprechend der GLOBOSCAN Daten, die von der Internationalen Agentur f\u00fcr Krebsforschung (International Agency for Research into Cancer \/ IARC) im Auftrag der Weltgesundheitsorganisation (World Health Organisation \/ WHO 2012) ver\u00f6ffentlicht wurden, stellt das Zervixkarzinom das 3.h\u00e4ufigste Karzinom und die 4.h\u00e4ufigste Todesursache weltweit dar (Abbildung 3.1). Die h\u00f6chste Morbidi\u00e4t (Frauen, die an einem Zervixkarzinom erkranken) [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/\" \/>\n<meta property=\"og:site_name\" content=\"Eurocytology\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-26T07:39:11+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/lnx.eurocytology.eu\/sites\/default\/files\/styles\/max\/public\/images\/2092_1427721074.png?itok=5RgXbnz3\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/\",\"url\":\"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/\",\"name\":\"3. Epidemiologie und \u00c4tiologie des Zervixkarzinoms - Eurocytology\",\"isPartOf\":{\"@id\":\"https:\/\/www.eurocytology.eu\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/lnx.eurocytology.eu\/sites\/default\/files\/styles\/max\/public\/images\/2092_1427721074.png?itok=5RgXbnz3\",\"datePublished\":\"2023-03-17T08:43:05+00:00\",\"dateModified\":\"2023-04-26T07:39:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/#primaryimage\",\"url\":\"http:\/\/lnx.eurocytology.eu\/sites\/default\/files\/styles\/max\/public\/images\/2092_1427721074.png?itok=5RgXbnz3\",\"contentUrl\":\"http:\/\/lnx.eurocytology.eu\/sites\/default\/files\/styles\/max\/public\/images\/2092_1427721074.png?itok=5RgXbnz3\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.eurocytology.eu\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Courses\",\"item\":\"https:\/\/www.eurocytology.eu\/course\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Zervixzytologie (Auf dem Laufenden, 2016)\",\"item\":\"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"3. Epidemiologie und \u00c4tiologie des Zervixkarzinoms\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.eurocytology.eu\/#website\",\"url\":\"https:\/\/www.eurocytology.eu\/\",\"name\":\"Eurocytology\",\"description\":\"The Eurocytology project is supported by the Leonardo da Vinci program with the aim of increasing access to training in clinical cytology and of harmonising training in this important specialty of pathology throughout the EU.\",\"publisher\":{\"@id\":\"https:\/\/www.eurocytology.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.eurocytology.eu\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.eurocytology.eu\/#organization\",\"name\":\"Eurocytology\",\"url\":\"https:\/\/www.eurocytology.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.eurocytology.eu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.eurocytology.eu\/wp-content\/uploads\/2023\/02\/logo_white.png\",\"contentUrl\":\"https:\/\/www.eurocytology.eu\/wp-content\/uploads\/2023\/02\/logo_white.png\",\"width\":250,\"height\":76,\"caption\":\"Eurocytology\"},\"image\":{\"@id\":\"https:\/\/www.eurocytology.eu\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"3. Epidemiologie und \u00c4tiologie des Zervixkarzinoms - Eurocytology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/","og_locale":"de_DE","og_type":"article","og_title":"3. Epidemiologie und \u00c4tiologie des Zervixkarzinoms - Eurocytology","og_description":"Epidemiologie Entsprechend der GLOBOSCAN Daten, die von der Internationalen Agentur f\u00fcr Krebsforschung (International Agency for Research into Cancer \/ IARC) im Auftrag der Weltgesundheitsorganisation (World Health Organisation \/ WHO 2012) ver\u00f6ffentlicht wurden, stellt das Zervixkarzinom das 3.h\u00e4ufigste Karzinom und die 4.h\u00e4ufigste Todesursache weltweit dar (Abbildung 3.1). Die h\u00f6chste Morbidi\u00e4t (Frauen, die an einem Zervixkarzinom erkranken) [&hellip;]","og_url":"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/","og_site_name":"Eurocytology","article_modified_time":"2023-04-26T07:39:11+00:00","og_image":[{"url":"http:\/\/lnx.eurocytology.eu\/sites\/default\/files\/styles\/max\/public\/images\/2092_1427721074.png?itok=5RgXbnz3"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/","url":"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/","name":"3. Epidemiologie und \u00c4tiologie des Zervixkarzinoms - Eurocytology","isPartOf":{"@id":"https:\/\/www.eurocytology.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/#primaryimage"},"image":{"@id":"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/#primaryimage"},"thumbnailUrl":"http:\/\/lnx.eurocytology.eu\/sites\/default\/files\/styles\/max\/public\/images\/2092_1427721074.png?itok=5RgXbnz3","datePublished":"2023-03-17T08:43:05+00:00","dateModified":"2023-04-26T07:39:11+00:00","breadcrumb":{"@id":"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/#primaryimage","url":"http:\/\/lnx.eurocytology.eu\/sites\/default\/files\/styles\/max\/public\/images\/2092_1427721074.png?itok=5RgXbnz3","contentUrl":"http:\/\/lnx.eurocytology.eu\/sites\/default\/files\/styles\/max\/public\/images\/2092_1427721074.png?itok=5RgXbnz3"},{"@type":"BreadcrumbList","@id":"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/3-epidemiologie-und-aetiologie-des-zervixkarzinoms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.eurocytology.eu\/"},{"@type":"ListItem","position":2,"name":"Courses","item":"https:\/\/www.eurocytology.eu\/course\/"},{"@type":"ListItem","position":3,"name":"Zervixzytologie (Auf dem Laufenden, 2016)","item":"https:\/\/www.eurocytology.eu\/de\/course\/zervixzytologie-auf-dem-laufenden-2016\/"},{"@type":"ListItem","position":4,"name":"3. Epidemiologie und \u00c4tiologie des Zervixkarzinoms"}]},{"@type":"WebSite","@id":"https:\/\/www.eurocytology.eu\/#website","url":"https:\/\/www.eurocytology.eu\/","name":"Eurocytology","description":"The Eurocytology project is supported by the Leonardo da Vinci program with the aim of increasing access to training in clinical cytology and of harmonising training in this important specialty of pathology throughout the EU.","publisher":{"@id":"https:\/\/www.eurocytology.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eurocytology.eu\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.eurocytology.eu\/#organization","name":"Eurocytology","url":"https:\/\/www.eurocytology.eu\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.eurocytology.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.eurocytology.eu\/wp-content\/uploads\/2023\/02\/logo_white.png","contentUrl":"https:\/\/www.eurocytology.eu\/wp-content\/uploads\/2023\/02\/logo_white.png","width":250,"height":76,"caption":"Eurocytology"},"image":{"@id":"https:\/\/www.eurocytology.eu\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/course\/5106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/course"}],"about":[{"href":"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/types\/course"}],"version-history":[{"count":2,"href":"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/course\/5106\/revisions"}],"predecessor-version":[{"id":5172,"href":"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/course\/5106\/revisions\/5172"}],"up":[{"embeddable":true,"href":"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/course\/5099"}],"wp:attachment":[{"href":"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/media?parent=5106"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/tags?post=5106"},{"taxonomy":"course_area","embeddable":true,"href":"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/course_area?post=5106"},{"taxonomy":"authors","embeddable":true,"href":"https:\/\/www.eurocytology.eu\/de\/wp-json\/wp\/v2\/authors?post=5106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}